Investigation of the potential role of TGR5 in pancreatic cancer by a comprehensive molecular experiments and the liquid chromatography mass spectrometry (LC–MS) based metabolomics

BACKGROUND: Takeda G protein receptor 5 (TGR5) is widely recognized as a potential drug target for the treatment of metabolic diseases. TGR5 is not only a metabolic regulator, but also has a potential role that participating in developing and progressing of gastrointestinal cancer. We aimed to inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Yangyang, Li, Guoping, Li, Jianke, Gao, Shanshan, Lei, Ming, Gong, Gaoquan, Li, Changyu, Chen, Yi, Wang, Chenggang, Wang, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188013/
https://www.ncbi.nlm.nih.gov/pubmed/35689739
http://dx.doi.org/10.1007/s12672-022-00504-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188013/
https://www.ncbi.nlm.nih.gov/pubmed/35689739
http://dx.doi.org/10.1007/s12672-022-00504-2

Ejemplares similares